{"database": "openregs", "table": "documents", "rows": [["FDA-2015-N-0101-1372", "FDA", "FDA-2015-N-0101", "021 Reference 10 - FDA_Letter_regarding_Deferral_of_Benzalkonium_Chloride re Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2017-12-20T05:00:00Z", 2017, 12, null, null, "2017-12-20T14:56:00Z", null, 0, 0, "0900006482cea90b"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-N-0101-1372"], "units": {}, "query_ms": 166.58254014328122, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}